433922-57-7Relevant articles and documents
Synthesis and anticancer evaluation of amide derivatives of imidazo-pyridines
Rani, Chekuri Sharmila,Reddy, Alugubelli Gopi,Susithra,Mak, Kit-Kay,Pichika, Mallikarjuna Rao,Reddymasu, Sreenivasulu,Rao, Mandava Venkata Basaveswara
, p. 74 - 83 (2020/10/06)
A novel series of amide functionalized imidazo[1,2-a]pyridine (14a–14j) derivatives were synthesized and screened for their anticancer activities against breast (MCF-7 and MDA-MB-231), lung (A549), and prostate (DU-145) cancer cell lines using MTT assay with etoposide as the standard reference drug. Among them, compound 14j showed highest potency in anticancer activities against MCF-7, MDA-MB-231, A549, and DU-145 cell lines with IC50 values of 0.021 ± 0.0012 μM, 0.95 ± 0.039 μM, 0.091 ± 0.0053 μM, and 0.24 ± 0.032 μM, respectively.
PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF
-
Paragraph 0176-0178, (2014/05/07)
The present invention relates to a pyridonaphthyridine compound as represented by general formula (I), which has a dual PI3K and mTOR inhibition effect, and its pharmaceutically acceptable salt, stereoisomer and deuteride thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the specification; the present invention also relates to a method for preparing said compound, a pharmaceutical composition and a pharmaceutical formulation containing said compound, and uses of said compound in treating and/or preventing a proliferative disease and in the manufacture of a medicament for treating and/or preventing a proliferative disease.
6-O-carbamoyl ketolide antibacterials
-
, (2008/06/13)
6-O-Carbamoyl ketolide antibacterials of the formula: wherein R1, R2, R3, R4, R5, R6, X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.